Find the right
blood pressure medication
using your DNA.
Hypertension is the leading preventable cause of death in the world.
Geneticure's patented test uses a sample of your DNA to recommend a personalized treatment plan, just for you.
Using the DNA on a cheek swab, Geneticure recommends which hypertension medication(s) may give you the biggest drop in blood pressure:
Fewer prescriptions.
Fewer office visits.
Less trial-and-error.
Your body is unique. Doctors don't know if a blood pressure medication will work until you try it. If it doesn't work, they might add or try another. This trial-and-error costs time and money. Some medications can even make your blood pressure go up.
Geneticure's test looks at 17 genotypes and 11 genes* to determine how your body responds to each medication. Your personalized report helps your doctor prescribe the right medication from the start.
Read our research
What our patients say:
What's in my report?
Different blood pressure treatments target different systems in your body. Your DNA can predict which system is most likely to respond to treatment. Your Geneticure report describes the responsiveness of 3 of your body's main organ systems:
Cardiac system
Controls how hard and fast your heart beats
Vascular system
Controls the tightening of blood vessels
Renal system
Controls the absorption of sodium and water in your kidneys
Who is Geneticure?
We're a team of hypertension expert scientists and doctors based in Rochester, Minnesota, home of the Mayo Clinic — which is also an investor in Geneticure. For 10 years we've put science and innovation to work, taking personalized medicine to the next level, unmatched in the world of pharmacogenomics. Contact us.
Notable investors:
Our team:
Scott Snyder
CEO
Scott spent 10 years in entrepreneurial roles leading Target Corporation businesses in Minneapolis; most recently as director of a strategic advisory group for over $10 Billion of consumer categories including OTC pharmacy. Scott's experience in consumer insights, analytics, digital marketing, and finance along with his longtime passion for investments in developmental stage biotechnology, led to his co-founding of Geneticure with Eric Snyder, Ryan Sprissler, and Tom Olson.
Eric Snyder, PhD
COO
Dr. Snyder completed his PhD at the University of Minnesota and performed his research training at Mayo Clinic as a pre-doctoral fellow and post-doctoral fellow in Cardiovascular Diseases with a second post-doctoral fellowship in Nephrology and Hypertension. He was an assistant professor in the College of Pharmacy at the University of Arizona and then moved on to the University of Minnesota before co-founding Geneticure.
Ryan Sprissler, PhD
CSO
Dr. Sprissler is a founding member of the Center for Applied Genetics and Genomic Medicine and Lead Scientist managing the University of Arizona Genetics Core facility specializing in cutting edge genomic technology. An industry pioneer, he has leveraged several partnerships fueling the high growth industry of genomic testing. With 15 years of experience in genetic assay design/testing he is a current member of the Association for Bioresource Facilities (ABRF), the Association for Laboratory Automation (ALA) & the American Association for the Advancement of Science (AAAS).
Ramsey Kilani, MD
Board of Directors
Dr. Ramsey Kilani is a physician, scientist, entrepreneur, and business leader with over twenty-five years of experience across the healthcare, life sciences, and technology sectors. In addition to nearly two decades of investigational molecular biology research in the academic setting, Ramsey has been a founder or C-level executive in multiple companies in the commercial diagnostics space over the past 10 years, leading those organizations to commercial success and acquisition. Dr. Kilani's educational background includes degrees from the University of Arizona, Northwestern University, and Duke University. His career exemplifies a blend of clinical excellence, scientific research, and strategic business acumen, making him a leader in bridging the gap between medicine and technology.
Brad Wilson
Board of Advisors
Brad Wilson is CEO Emeritus of BlueCross BlueShield of NC, the state's largest health insurer. Once a practicing attorney and then General Counsel to N.C. Governor James B Hunt, Jr., Wilson joined BCBSNC as General Counsel where during his 22 year career he served in four different executive leadership roles, the last as President and CEO from 2010-2018. Under his leadership, the company successfully implemented the ACA in all 100 counties, doubled top line revenue and served approximately 3.9 million North Carolinians through a diverse product portfolio. He was a leader within the BCBS Association, serving on the Association Board and numerous standing and special committees.
Thomas Olson, PhD
CCO
Dr. Olson is an Associate Professor of Medicine and Science and Consultant in the Department of Cardiovascular Medicine at Mayo Clinic where he sees patients in the Division of Preventive Cardiology. He is the Director of the Clinical Integrative Physiology Research Laboratory which is funded by the National Institutes of Health, American Heart Association, and Industry.
Timothy Curry, MD, PhD
Medical Director
Dr. Curry has lead large clinical pharmacogenomic implementation projects and is a leader in pharmacogenomic education. He is the Director of the Education Program of the Mayo Clinic Center for Individualized Medicine as well as the Vice Chair of Practice for the Department of Anesthesiology and Perioperative Medicine, also at Mayo Clinic. He is also an integrative physiologist with special expertise in cardiopulmonary and neural physiology.
Bruce Johnson, PhD
Board of Advisors
Dr. Johnson is a Professor of Medicine and Physiology at Mayo Clinic, Rochester, Minnesota. Dr. Johnson has an established, NIH-funded laboratory to study genetics and cardiorespiratory function in patients with heart failure as well as grants from NSF and DOD focused on environmental physiology. Dr. Johnson received his BA from Pacific Lutheran University, Masters from St. Cloud State University and PhD in Respiratory Physiology and Biodynamics from the University of Wisconsin, Madison. Dr. Johnson completed a fellowship through the Mayo Graduate School of Medicine, Mayo Clinic College of Medicine and is a Consultant in the Division of Cardiovascular Diseases.
David Herbert
EVP of Strategy
David spent over 20 years in leadership roles at Mayo Clinic, including Chief Administrative Officer of Mayo Medical Laboratories; Chair of Mayo Clinic Global Business Solutions; and Director of Technology Commercialization at Mayo Medical Ventures. David is an emeritus member of the Mayo Clinic staff, a board member and treasurer of the national Myotonic Dystrophy Foundation, and chair of the Southeast Minnesota Capital Fund.
Don Wright
Board of Advisors
Don Wright spent the past decade growing Assurex Health from technology invented at Mayo Clinic and Cincinnati Children's Hospital Medical Center to a company of almost 500 employees serving over 500,000 people with mental health conditions. Assurex Health was acquired in 2016 by Myriad Genetics allowing Don to use his more than 25 years of experience in the informatics, product development, operations and life sciences fields, to assisting others turn their ideas into hyper-growth companies.
Carl Jepsen
Director of Operations
Carl has 18 years of banking, finance and commercial real estate experience. Prior to joining Geneticure, he most recently held the position of a Business Banking Relationship Manager. In that role, he consulted with clients and prospective clients, in all stages of growth, regarding process management, transition, and business strategies.
Robin Thomas
Staff Software Engineer
Robin has implemented new design systems at Google, managed merchant Bitcoin adoption for Coinbase, and lead machine learning initiatives at Best Buy's digital headquarters. He loves teaching code as much as writing it, and was among the highest-rated instructors of General Assembly's Web Development Immersive. He encourages you to try the Konami Code on this site.
- See our full team ›
